Related Experiment Videos
Radioimaging of human ovarian carcinoma xenograft in nude mice
A Manetta1, P G Satyaswaroop, T Hamilton
1Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Abstract:
Human ovarian carcinomas in nude mice were radioimaged using a well-characterized antibody against a tumor-associated antigen (CA 125) and three transplantable human ovarian carcinoma tumor lines: NIH:OVCAR 3, NIH:OVCAR 5, and NIH:OVCAR 9. Radioiodinated monoclonal antibody OC125 was used in these studies. In order to establish the optimal conditions for imaging, tumor/blood ratios were determined. Gamma scintigraphy of nude mice bearing subcutaneous transplants of human ovarian carcinomas 3-4 days after 131I-OC125 administration demonstrated selective localization of the radiolabeled monoclonal antibody by these tumors without need for any background subtraction techniques.
Insights
Researchers successfully radioimaged human ovarian carcinomas in mice using a targeted antibody. The study demonstrated selective tumor localization of the radiolabeled antibody, paving the way for improved diagnostic imaging of ovarian cancer.
Area of Science:
- Oncology
- Immunology
- Medical Imaging
Background:
- Human ovarian carcinomas are a significant health concern.
- Accurate diagnostic imaging is crucial for effective treatment.
- Tumor-associated antigens present potential targets for imaging agents.
Purpose of the Study:
- To evaluate the efficacy of radioiodinated monoclonal antibody OC125 for radioimaging human ovarian carcinomas in vivo.
- To determine optimal conditions for imaging by assessing tumor/blood ratios.
- To assess the selective localization of the antibody in ovarian tumors.
Main Methods:
- Utilized three transplantable human ovarian carcinoma lines (NIH:OVCAR 3, 5, 9) in nude mice.
- Administered radioiodinated monoclonal antibody OC125 (131I-OC125).
- Performed gamma scintigraphy 3-4 days post-administration.
Main Results:
- Demonstrated selective localization of 131I-OC125 in human ovarian carcinomas xenografted in nude mice.
- Achieved significant tumor/blood ratios, indicating good target-to-background signal.
- Imaging was effective without the need for background subtraction techniques.
Conclusions:
- Radioiodinated monoclonal antibody OC125 shows promise for radioimaging human ovarian carcinomas.
- The antibody exhibits selective tumor targeting, facilitating non-invasive tumor detection.
- This approach could enhance diagnostic capabilities for ovarian cancer management.